Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?

Article Properties
  • Language
    English
  • Publication Date
    2024/01/18
  • Indian UGC (journal)
  • Refrences
    28
  • Mohammad Al Hariri Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany
  • Markus Munder Department of Hematology and Oncology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany
  • Norbert Pfeiffer Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany
  • Joanna Wasielica-Poslednik Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany ORCID (unauthenticated)
Abstract
Cite
Al Hariri, Mohammad, et al. “Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?”. Journal of Clinical Medicine, vol. 13, no. 2, 2024, p. 565, https://doi.org/10.3390/jcm13020565.
Al Hariri, M., Munder, M., Pfeiffer, N., & Wasielica-Poslednik, J. (2024). Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?. Journal of Clinical Medicine, 13(2), 565. https://doi.org/10.3390/jcm13020565
Al Hariri, Mohammad, Markus Munder, Norbert Pfeiffer, and Joanna Wasielica-Poslednik. “Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?”. Journal of Clinical Medicine 13, no. 2 (2024): 565. https://doi.org/10.3390/jcm13020565.
Al Hariri M, Munder M, Pfeiffer N, Wasielica-Poslednik J. Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?. Journal of Clinical Medicine. 2024;13(2):565.
Journal Categories
Medicine
Internal medicine
Medicine
Medicine (General)
Refrences
Title Journal Journal Categories Citations Publication Date
Monoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes Leukemia & Lymphoma
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
3 2022
Monoclonal gammopathies of clinical significance

Hematology
  • Education: Education (General)
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
34 2020
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management

American Journal of Hematology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
462 2020
Recurrence of paraproteinemic crystalline keratopathy after corneal transplantation: A case of monoclonal gammopathy of ocular significance American Journal of Ophthalmology Case Reports 6 2020
Paraproteinemic keratopathy associated with monoclonal gammopathy of undetermined significance (MGUS): clinical findings in twelve patients including recurrence after keratoplasty

Acta Ophthalmologica
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
11 2019
Refrences Analysis